| Product Name |
Fluticasone EP Impurity D |
| Product Category | Impurities, Intermediates |
| Sub-Category | Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No | 73205-13-7 |
| Catalog Number | GS.37.FLT.04 |
| Chemical Name/Synonyms | (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-17-((methylthio)carbonyl)-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl Propionate; Ticabesone Propionate; Fluticasone S-methyl Impurity; S-Methyl Fluticasone Propionate; (6a,11ß,16a,17a)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carbothioic Acid S-Methyl Ester; S-Methyl 6α, 9α-difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-propionyloxyandrosta-1,4-diene-17β-carbothioate; Fluticasone Propionate Related Compound D (USP); |
| Molecular Weight | 482.58 |
| Molecular Formula | C25H32F2O5S |
| Purity | NLT 95 % |
| Appearance | White Solid |
| Solubility | DMSO, Methanol |
| Applications | It is an impurty of Fluticasone Pripionate which is used to treat asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis (hay fever), and various inflammatory skin conditions |
| Inventory Status | QC Pending |